Thromboprophylaxis in pediatric patients with earthquake-related crush syndrome: a single centre experience

Feryal Karahan1, Selma Ünal1, Özlem Tezol2

  • 1Faculty of Medicine, Department of Pediatric Hematology, Mersin University, Mersin, Turkey.

PubMed

Insights

Pediatric patients with crush injuries from earthquakes received anticoagulant therapy to prevent venous thromboembolism (VTE). This approach resulted in a low VTE rate of 2.1% in this high-risk group.

Area of Science:

  • Pediatric Critical Care Medicine
  • Trauma Surgery
  • Hematology

Background:

  • Crush injuries significantly elevate the risk of venous thromboembolism (VTE).
  • Limited data exists on managing anticoagulant therapy for VTE prophylaxis in pediatric patients with crush injuries, particularly those from mass casualty events.
  • Earthquake-related crush syndrome presents unique challenges for VTE risk assessment and management in children.

Purpose of the Study:

  • To share clinical experience in managing anticoagulant thromboprophylaxis for pediatric patients with earthquake-related crush syndrome.
  • To evaluate the effectiveness of an adapted VTE prevention guideline in this specific pediatric trauma population.
  • To determine the VTE rate in pediatric crush injury patients following a standardized thromboprophylaxis protocol.

Main Methods:

  • A cohort of pediatric patients with earthquake-related crush syndrome was assessed for VTE risk.
  • VTE risk stratification was performed by adapting guidelines for perioperative VTE prevention in adolescents due to the absence of pediatric trauma-specific VTE guidelines.
  • Anticoagulant thromboprophylaxis with enoxaparin was administered based on VTE risk level (low, moderate, high) and age.

Main Results:

  • Forty-nine pediatric patients with earthquake-related crush syndrome were included.
  • VTE risk was stratified: 14.6% low risk, 27.1% moderate risk, and 58.3% high risk.
  • Prophylactic enoxaparin was given to moderate-risk patients and high-risk patients under 13 years unable to mobilize early, and to all high-risk patients aged 13 years and older.

Conclusions:

  • The implemented decision-making algorithm for thromboprophylaxis in pediatric crush syndrome patients was associated with a low VTE rate of 2.1%.
  • Adapting existing VTE guidelines for perioperative adolescent patients proved effective for risk assessment and prophylaxis in earthquake-related crush injuries.
  • This study highlights the importance of proactive VTE prophylaxis in pediatric trauma patients, even in resource-limited disaster settings.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563